Brought to you by 
JHP and SpePharm acquire Dantrium from P&G
Sep 2008
Executive Summary
Procter & Gamble has sold its muscle relaxant Dantrium (dantrolene) to JHP Pharmaceuticals (sterile injectable drugs for the hospital market) and Dutch specialty pharmaco SpePharm Holding BV.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Product Purchase
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
JHP and SpePharm acquire Dantrium from P&G
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice